Overview
Sandeep Prabhu is a Pediatric Radiologist and a Radiologist in Oklahoma City, Oklahoma. Dr. Prabhu has been practicing medicine for over 37 years and is rated as an Experienced provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top area of expertise is Neurofibromatosis Type 1 (NF1).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
900 Ne 10th St, Ouhp Family Medicine, Oklahoma City, OK 73104
1200 Childrens Ave, Suite B770, Oklahoma City, OK 73104
Additional Areas of Focus
Dr. Prabhu has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Ou Health Partners Inc
Benjamin Cornwell is a Radiologist in Oklahoma City, Oklahoma. Dr. Cornwell has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top areas of expertise are Pediatric Low-Grade Glioma (pLGG), Cerebral Arteriovenous Malformation, Subarachnoid Hemorrhage, Bone Marrow Aspiration, and Gamma Knife Radiosurgery.
Ou Health Partners Inc
Farooq Choudhry is a Neuroradiologist and a Radiologist in Oklahoma City, Oklahoma. Dr. Choudhry is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top areas of expertise are Stroke, Pediatric Low-Grade Glioma (pLGG), Cerebral Arteriovenous Malformation, and Subarachnoid Hemorrhage.
Ou Health Partners Inc
Mohammad Alberawi is a Neuroradiologist and a Radiologist in Oklahoma City, Oklahoma. Dr. Alberawi has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top areas of expertise are Schizencephaly, Porencephaly, Stroke, and Pediatric Low-Grade Glioma (pLGG).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers